KETOROLAC MARKET ANALYSIS

Ketorolac Market, by Indication (Fever, Inflammation, Surgery Pain, Dysmenorrhea, Others), by Formulation (Oral, Parental, Topical), by Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI4170
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Ketorolac Market Regional Analysis

On the basis of region global ketorolac market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to witness significant growth in global ketorolac market owing to pharmaceutical companies focusing on Product launches in non-steroidal anti-inflammatory drugs for management of severe and moderate pain. For instance, In 2018, Nephron pharmaceuticals Corporation, launched a novel opoid free analgesic drug BKK with drug content Bupivacaine, ketorolac and ketamine.

In Europe, pharmaceutical companies are focusing on product approval in region to strengthen their market share in global ketorolac market. For instance, in 2018 Omerous Corporation announced approval for sales of phenylephrine and ketorolac solution (OMIDRA) as an intraocular solution by European Medical Agency.